Related references
Note: Only part of the references are listed.Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma
May Elbanna et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Targeting Tyrosine kinases in Renal Cell Carcinoma: New Bullets against Old Guys
Teresa Alonso-Gordoa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Novel Insights Into E3 Ubiquitin Ligase in Cancer Chemoresistance
Li Yang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2018)
E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin-33 Receptor
Qian Li et al.
IMMUNITY (2018)
VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma
Jing Zhang et al.
SCIENCE (2018)
Consequences of VHL Loss on Global DNA Methylome
Claire M. Robinson et al.
SCIENTIFIC REPORTS (2018)
The epigenetic landscape of renal cancer
Mark R. Morris et al.
NATURE REVIEWS NEPHROLOGY (2017)
Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL
E. Hasanov et al.
ONCOGENE (2017)
Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation
Chiara Maniaci et al.
NATURE COMMUNICATIONS (2017)
Phosphorylation and Ubiquitination Regulate Protein Phosphatase 5 Activity and Its Prosurvival Role in Kidney Cancer
Natela Dushukyan et al.
CELL REPORTS (2017)
Renal cell carcinoma
James J. Hsieh et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas
Xiaohu Tang et al.
CANCER RESEARCH (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
Choosing the right cell line for renal cell cancer research
Klaudia K. Brodaczewska et al.
MOLECULAR CANCER (2016)
Inhibition of Ras/Raf/MEK/ERK Pathway Signaling by a Stress-Induced Phospho-Regulatory Circuit
Daniel A. Ritt et al.
MOLECULAR CELL (2016)
The RAS/MAPK Axis Gets Stressed Out
Scott A. Foster et al.
MOLECULAR CELL (2016)
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
W. Marston Linehan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma
Wu Xiao-fen et al.
OPEN MEDICINE (2016)
Di-Ras2 Protein Forms a Complex with SmgGDS Protein in Brain Cytosol in Order to Be in a Low Affinity State for Guanine Nucleotides
Yoshitaka Ogita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Regulation of the DNA damage response by ubiquitin conjugation
Kerstin Brinkmann et al.
FRONTIERS IN GENETICS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Caleb F. Davis et al.
CANCER CELL (2014)
Candidate Tumor Suppressor and pVHL Partner Jade-1 Binds and Inhibits AKT in Renal Cell Carcinoma
Liling Zeng et al.
CANCER RESEARCH (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin et al.
NATURE (2012)
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang et al.
NATURE (2012)
Survival After Complete Surgical Resection of Multiple Metastases From Renal Cell Carcinoma
Angela L. Alt et al.
CANCER (2011)
Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations
Paul K. Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Signaling pathways in renal cell carcinoma
Gowrishankar Banumathy et al.
CANCER BIOLOGY & THERAPY (2010)
The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation
William E. Tidyman et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
The RAS/MAPK syndromes: Novel roles of the RAS pathway in human genetic disorders
Yoko Aoki et al.
HUMAN MUTATION (2008)
Jade-1 inhibits Wnt signalling by ubiquitylating β-catenin and mediates Wnt pathway inhibition by pVHL
Vipul C. Chitalia et al.
NATURE CELL BIOLOGY (2008)
The inflammatory cytokine tumor necrosis factor-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells
Hagen Kulbe et al.
CANCER RESEARCH (2007)
The von Hippel-Lindau tumor suppressor protein controls ciliogenesis by orienting microtubule growth
Bernhard Schermer et al.
JOURNAL OF CELL BIOLOGY (2006)
Targeted agents for the treatment of advanced renal cell carcinoma
WM Stadler
CANCER (2005)
von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination
AV Kuznetsova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Di-Ras, a distinct subgroup of Ras family GTPases with unique biochemical properties
K Kontani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structural basis for the recognition of hydroxyproline in αIF-1α by pVHL
WC Hon et al.
NATURE (2002)
The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C
H Okuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
